Atea Pharmaceuticals (AVIR) Earnings Date & Reports

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AVIR is expected to report earnings to rise 2.30% to -40 cents per share on May 07

Atea Pharmaceuticals AVIR Stock Earnings Reports

Q1'25

Est.

$-0.41

Q4'24

Missed

by $0.05

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.18

Q1'24

Missed

by $0.14

The last earnings report on March 06 showed earnings per share of -40 cents, missing the estimate of -34 cents. With 245.18K shares outstanding, the current market capitalization sits at 243.75M.

View a ticker or compare two or three

Compare

AVIR